The growing and evolving science in the field of biotech is raising demand for high-skilled jobs in India as told by Kiran Mazumdar-Shaw, chairperson and managing director, Biocon, a centre for advanced learning in applied biosciences.
The Biocon academy will in collaboration with Keck Graduate Institute (KGI), California, will offer a programme titled as the 'Biocon KGI Certificate Program in Biosciences’.
This collaboration of the two institutes is aiming to build a new all rounder, professionals of life sciences.
Shaw told that KGI is exceptionally competent through its faculty and high-tech infrastructure that also contain the ‘Amgen Bioprocessing Centre’ that facilitates Biocon to attempt to building professional cadres.
The focus of the academy will be on conducting experiments, knowledge application, along with the innovation skills of Indian bio scientists.
KGI has created a graduate-level curriculum that is applied in nature, with the help of Biocon’s collaboration with scientists and subject matter experts. The syllabus is intended to focus on teamwork and the one that reflects present industry dynamics, informed Sheldon M Schuster, President of Keck Graduate Institute.
The particulars of the course sates it to be a full-time 16 weeks duration course, with advance learning approach covering in industrial training sessions.
The course will commence from January 2014. The last applying date of online application submission is 6 December, 2013.
This course will incur the applicant a cost of Rs 6 lakh in which s/he need to pay Rs 1.5 lakh only, since there is also a Biocon scholarship of 75% of the programme fee.
The eligibility criterion is decided as candidates must possess a BE/B. Tech in biotechnology/industrial biotechnology, M. Sc in biotechnology/microbiology/biochemistry/biology, and B. Pharm maintaining a CGPA of 7.5 (71 percentage) or above.
The faculty members would include S S Easwaran, Dr. Susan Bain, Dr. Anastasia Levitin, Dr. Michael Jamieson.
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.